UK markets open in 1 hour 46 minutes
  • NIKKEI 225

    27,920.87
    +346.44 (+1.26%)
     
  • HANG SENG

    19,843.33
    +393.10 (+2.02%)
     
  • CRUDE OIL

    71.87
    +0.41 (+0.57%)
     
  • GOLD FUTURES

    1,807.60
    +6.10 (+0.34%)
     
  • DOW

    33,781.48
    +183.56 (+0.55%)
     
  • BTC-GBP

    14,040.85
    +271.60 (+1.97%)
     
  • CMC Crypto 200

    405.92
    +11.23 (+2.85%)
     
  • ^IXIC

    11,082.00
    +123.45 (+1.13%)
     
  • ^FTAS

    4,082.24
    -11.44 (-0.28%)
     

Why Beam Therapeutics Stock Rocketed Higher This Week

Shares of the clinical-stage base-editing company Beam Therapeutics (NASDAQ: BEAM) stormed higher through the first four days of trading this week. Beam's sizable uptick seems to simply be a rebound following last week's 23% drop in its share price. Clinical-stage biotech stocks have been extremely volatile this year, thanks to rising interest rates, geopolitical turmoil, and investors' general aversion to risk right now.